Press Releases June 13, 2025: MaaT Pharma Presents Updated Positive Data in Early Access Program for Xervyteg® at the EHA Congress Validating High Efficacy Observed in Pivotal ARES Study in Acute Graft-versus-Host Disease MaaT Pharma Presents Updated Positive Data in Early Access Program for Xervyteg® at the EHA…MaaT PharmaJune 13, 2025
Press Releases May 14, 2025: MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European Hematology Association (EHA) Annual Congress MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European…MaaT PharmaMay 14, 2025
